Search research articles
Contact Us
Filters
Showing results (1401-1410 of 2,887) with videos related to
Page
of 289
Sort By:
Applied and Environmental Microbiology
|
May 12, 2009
Zoosporic tolerance to pH stress and its implications for Phytophthora species in aquatic ecosystems
Ping Kong, Gary W Moorman, John D Lea-Cox, et al.
The Oncologist
|
April 7, 2009
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine
Jeffrey S Ross, Elzbieta A Slodkowska, W Fraser Symmans, et al.
Biological Psychiatry
|
April 21, 2009
Effect of childhood emotional abuse and age on cortisol responsivity in adulthood
Linda L Carpenter, Audrey R Tyrka, Nicole S Ross, et al.
Calcified Tissue International
|
November 4, 1998
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
H N Rosen, A C Moses, J Garber, et al.
Trials
|
January 22, 2016
Characterisation of trials where marketing purposes have been influential in study design: a descriptive study
Virginia Barbour, Druin Burch, Fiona Godlee, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2018
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis
Jean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
Foods (Basel, Switzerland)
|
September 9, 2022
Effect of Genotype and Environment on Food-Related Traits of Organic Winter Naked Barleys
Jordyn S Bunting, Andrew S Ross, Brigid M Meints, et al.
Radiology
|
October 1, 1987
Vertebral hemangiomas: MR imaging
J S Ross, T J Masaryk, M T Modic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 1, 1997
Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma
M W Riben, J H Malfetano, T Nazeer, et al.
JCI Insight
|
November 8, 2022
BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasm
Gerardo Lopez-Perez, Ranjula Wijayatunge, Kelly B McCrum, et al.
Page
of 289
Search research articles
Search
Showing results (1401-1410 of 2,887) with videos related to
Sort By:
Page
of 289
Applied and Environmental Microbiology
|
May 12, 2009
Zoosporic tolerance to pH stress and its implications for Phytophthora species in aquatic ecosystems
Ping Kong, Gary W Moorman, John D Lea-Cox, et al.
The Oncologist
|
April 7, 2009
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine
Jeffrey S Ross, Elzbieta A Slodkowska, W Fraser Symmans, et al.
Biological Psychiatry
|
April 21, 2009
Effect of childhood emotional abuse and age on cortisol responsivity in adulthood
Linda L Carpenter, Audrey R Tyrka, Nicole S Ross, et al.
Calcified Tissue International
|
November 4, 1998
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
H N Rosen, A C Moses, J Garber, et al.
Trials
|
January 22, 2016
Characterisation of trials where marketing purposes have been influential in study design: a descriptive study
Virginia Barbour, Druin Burch, Fiona Godlee, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2018
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis
Jean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
Foods (Basel, Switzerland)
|
September 9, 2022
Effect of Genotype and Environment on Food-Related Traits of Organic Winter Naked Barleys
Jordyn S Bunting, Andrew S Ross, Brigid M Meints, et al.
Radiology
|
October 1, 1987
Vertebral hemangiomas: MR imaging
J S Ross, T J Masaryk, M T Modic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 1, 1997
Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma
M W Riben, J H Malfetano, T Nazeer, et al.
JCI Insight
|
November 8, 2022
BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasm
Gerardo Lopez-Perez, Ranjula Wijayatunge, Kelly B McCrum, et al.
Page
of 289